abstract |
The present invention is a therapeutic agent for treating and / or preventing a disease associated with cells expressing CLD18, including tumor-related diseases including gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, liver cancer, head and neck cancer, and gallbladder cancer. To provide useful antibodies. |